The potential role of nicotinamide on Leishmania tropica: An assessment of inhibitory effect, cytokines gene expression and arginase profiling.
Animals
Antiprotozoal Agents
/ immunology
Arginase
/ metabolism
Cell Line
Cytokines
/ genetics
Dose-Response Relationship, Drug
Drug Therapy, Combination
Gene Expression
/ drug effects
Inhibitory Concentration 50
Leishmania tropica
/ drug effects
Macrophages
/ drug effects
Meglumine Antimoniate
/ immunology
Mice
Molecular Docking Simulation
Niacinamide
/ immunology
Th1 Cells
/ immunology
Th2 Cells
/ immunology
Arginase activity
Combination therapy
Cytokine gene expression
Leishmania tropica
Nicotinamide
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
20
04
2020
revised:
30
05
2020
accepted:
11
06
2020
pubmed:
27
6
2020
medline:
29
5
2021
entrez:
27
6
2020
Statut:
ppublish
Résumé
Leishmaniasis represents a major health concern worldwide which has no effective treatment modality. Nicotinamide (NAm) has been used for a wide range of applications from anticancer to antimicrobial usage. This study aimed to assess the effect of NAm combination on Leishmania tropica Inhibition, as well as on cytokines gene expression and arginase (ARG) activity in L. tropica-infected macrophages in an in vitro model. The leishmanicidal effects of NAm and Glucantime (meglumine antimoniate, MA) alone and in combination (NAm/MA) were evaluated using a colorimetric assay and macrophage model. Additionally, immunomodulatory effects and enzymatic activity were assessed by analyzing Th1 and Th2 cytokines gene expression and ARG level, respectively, in infected macrophages treated with NAm and MA, alone and in combination. Findings indicated that the NAm/MA combination demonstrated greater inhibitory effects on L. tropica promastigotes and amastigotes compared with each drug individually. Docking results proved the affinity of NAm to IFN-γ, which can affirm the increased levels of IFN-γ, IL-12p40 and TNF-α as well as reductions in IL-10 secretion with a dose-response effect, especially in the combination group. The NAm/MA combination also showed a significant reduction in the level of ARG activity at all concentrations used compared to each drug individually. These findings indicate higher effectiveness of NAm plus MA in reducing parasite growth, promoting immune response and inhibiting ARG level. This combination should be considered as a potential therapeutic regimen for treatment of volunteer patients with anthroponotic cutaneous leishmaniasis (ACL) in future control programs.
Identifiants
pubmed: 32590317
pii: S1567-5769(20)31212-1
doi: 10.1016/j.intimp.2020.106704
pii:
doi:
Substances chimiques
Antiprotozoal Agents
0
Cytokines
0
Niacinamide
25X51I8RD4
Meglumine Antimoniate
75G4TW236W
Arginase
EC 3.5.3.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106704Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.